title: Promoting Therapeutic Innovation: What Do We Do About Drug-Device Combinations?
authors.affiliation: medical student at Harvard Medical School and research trainee in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women's Hospital in Boston. Throughout medical school, his research interests have f.
authors.forename: Bo
authors.initials: B
authors.lastname: Wang
authors.affiliation: associate professor of medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women's Hospital in Boston. He leads the Program on Regulation, Thera.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
mesh_terms: D003131:Combined Modality Therapy; D018795:Device Approval / Q000331:legislation & jurisprudence*; D004059:Diffusion of Innovation; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D014481:United States